{
    "organizations": [],
    "uuid": "f5aa60f2fc8343cde52b418a6e132b42813fe606",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vertex-pharma-says-fda-approved-sy/brief-vertex-pharma-says-fda-approved-symdeko-for-treating-underlying-cause-of-cystic-fibrosis-idUSFWN1Q21FP",
    "ord_in_thread": 0,
    "title": "BRIEF-Vertex Pharma Says FDA Approved SYMDEKO For Treating Underlying Cause Of Cystic Fibrosis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Vertex Pharmaceuticals Inc:\n* VERTEX PHARMACEUTICALS INC - FDA APPROVED SYMDEKO FOR TREATING UNDERLYING CAUSE OF CYSTIC FIBROSIS IN PEOPLE AGES 12 AND OLDER​\n* VERTEX PHARMACEUTICALS INC - ‍READY TO LAUNCH SYMDEKO AND WILL BEGIN SHIPPING IT TO PHARMACIES IN UNITED STATES THIS WEEK​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-12T23:56:00.000+02:00",
    "crawled": "2018-02-13T00:13:07.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "vertex",
        "pharmaceutical",
        "inc",
        "vertex",
        "pharmaceutical",
        "inc",
        "fda",
        "approved",
        "symdeko",
        "treating",
        "underlying",
        "cause",
        "cystic",
        "fibrosis",
        "people",
        "age",
        "vertex",
        "pharmaceutical",
        "inc",
        "launch",
        "symdeko",
        "begin",
        "shipping",
        "pharmacy",
        "united",
        "state",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}